Back to Results
First PageMeta Content
Imatinib / Pyridines / Chronic myelogenous leukemia / Carlo Gambacorti-Passerini / Organic chemistry / Piperazines / Pyrimidines / Oncologists


Imatinib Long Term Effects (ILTE) Study: An Independent, International Study in CML Patients C. Gambacorti-Passerini1, D.W. Kim2, F.X. Mahon3, G. Saglio4, F. Pane5, F. Guilhot6, M. W.N. Deininger7, A. Nagler8, A. Rambald
Add to Reading List

Document Date: 2010-01-04 03:57:59


Open Document

File Size: 70,08 KB

Share Result on Facebook

City

Napoli / Monza / Seoul / Bergamo / Milan / Tel Hashomer / Poitiers / Orbassano / /

Company

O A LE S S A / /

Country

France / United States / Italy / Israel / South Korea / /

Facility

Chaim Sheba Medical Center / Science University / Mary's Hospital / /

IndustryTerm

therapy for chronic myeloid leukemia / /

MedicalCondition

substantially higher second cancer / tendon shoulder gastritis heart failure herpes / uterus thyroiditis / nausea / pain / IARC cancer / pain gynecomastia / anasarca coxarthrosis diarrea fever / chronic myeloid leukemia / IMA otitis pneumonia pyomyositis / muscle cramps / second cancers / glutens biceps femoris skin rash surgery / cutaneous lesions rash/skin fragility diarrhea / /

MedicalTreatment

surgery / ccr / /

Organization

Chaim Sheba Medical Center / Institut Bergonié / Italian Drug Safety Agency / Oregon Health and Science University / Portland / /

Person

Victor Ségalen Bordeaux / /

Position

referring physician / /

SocialTag